Home The Word Brain My Amedeo FAQ Privacy About


Amedeo Chinese

For Medical Students & Physicians

A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever.

Download the free PDF: Amedeo Chinese PDF

  Osteoporosis

  Free Subscription


14.09.2026

2 Ann Intern Med
9 Osteoporos Int
1 PLoS One


   Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Ann Intern Med

  1. CHOU R, Ahmed AY, Hart EL, Totten AM, et al
    Effectiveness and Safety of Treatments to Prevent Fractures in People With Low Bone Mass or Primary Osteoporosis: A Living Systematic Review and Network Meta-analysis for the American College of Physicians (Version 1: Update Alert 2).
    Ann Intern Med. 2026 Sep 8. doi: 10.7326/ANNALS-26-02845.
    PubMed        

  2. QASEEM A, Mackey K, Shamliyan TA, Cross JT Jr, et al
    Pharmacologic Treatment of Primary Osteoporosis or Low Bone Mass to Prevent Fractures in Adults: A Living Clinical Guideline From the American College of Physicians (Version 1: Update Alert 2).
    Ann Intern Med. 2026 Sep 8. doi: 10.7326/ANNALS-26-02740.
    PubMed        


    Osteoporos Int

  3. YUKISHIMA T, Kobayakawa T, Hirano Y, Kanayama Y, et al
    Impact of oral glucocorticoids on the effectiveness of romosozumab: the multicenter OASIS cohort study.
    Osteoporos Int. 2026;37:1247-1256.
    PubMed         Abstract available

  4. LESLIE WD, Hans D, Johansson H, McCloskey EV, et al
    Adjusting fracture probability according to duration of diabetes: the Manitoba BMD Registry.
    Osteoporos Int. 2026 Apr 10. doi: 10.1007/s00198-026-08001.
    PubMed         Abstract available

  5. CHAN D, Chen W, Yabsley E, Pocock N, et al
    Demographic determinants of REMS-derived BMD and fragility score.
    Osteoporos Int. 2026;37:1125-1133.
    PubMed         Abstract available

  6. GLAVAS C, Ryan JR, Breasail MO, Gandham A, et al
    Does osteosarcopenia synergistically increase risk for incident falls and fractures? A systematic review and meta-analysis.
    Osteoporos Int. 2026 Mar 23. doi: 10.1007/s00198-026-07967.
    PubMed         Abstract available

  7. KANIS JA, McCloskey EV, Johansson H, Liu E, et al
    Predictive value of BMD for hip and other fractures: a meta-analysis to update FRAX.
    Osteoporos Int. 2026 Mar 12. doi: 10.1007/s00198-026-07925.
    PubMed         Abstract available

  8. VON BRACKEL FN, Dehne N, Kornak U, Barvencik F, et al
    Romosozumab is effective in patients with variants in LRP5, LRP6, or WNT1.
    Osteoporos Int. 2026;37:1267-1278.
    PubMed         Abstract available

  9. AL-MASHHADI ZK, Viggers R, Starup-Linde J, Langdahl BL, et al
    Systemic glucocorticoid use increases fracture risk similarly in individuals with and without type 2 diabetes: a Danish nationwide cohort study.
    Osteoporos Int. 2026 Sep 11. doi: 10.1007/s00198-026-08206.
    PubMed         Abstract available

  10. BEVERS MSAM, Wyers CE, van Rietbergen B, van den Bergh JP, et al
    Effects of romosozumab on the peripheral and axial skeleton in postmenopausal women at high fracture risk: real-world evidence from DXA and HR-pQCT data.
    Osteoporos Int. 2026 Sep 9. doi: 10.1007/s00198-026-08148.
    PubMed         Abstract available

  11. CONFAVREUX CB, Bouvard B, Blank R, Hadji P, et al
    Clinical guidance on evaluation and management of bone fragility in patients with monoclonal gammopathy of undetermined significance (MGUS): an IOF position statement.
    Osteoporos Int. 2026 Sep 8. doi: 10.1007/s00198-026-08178.
    PubMed         Abstract available


    PLoS One

  12. ANKER-HANSEN C, Pirouzifard M, Sundquist J, Sundquist K, et al
    Familial risks of hospital treated osteoporosis and fractures in first-, second- and third-degree relatives - A Swedish nationwide real-world family study.
    PLoS One. 2026;21:e0358074.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Osteoporosis is free of charge.

Privacy / Datenschutzerklärung | Imprint / Impressum